Reimbursement

A 2011 report by the U.S. Government Accountability Office (GAO) found that aggregate rates of coverage denials in the states reviewed, including denials of pre-authorizations and claims, ranged from 11% to 24%.1

Each denial has significant downstream impact on a practice: the average cost to rework a single claim is $252 and resource-intensive appeals can take months with no guarantee of success with many practices ending up with write-offs in the range of 1% to 5%.3

Regardless of number, denials can be detrimental to the health and sustainability of a practice.

2020 Modality Reimbursement Tool – Hip & Shoulder

2020 Modality Reimbursement Tool – Facet Joints

2020 Modality Reimbursement Tool – Knee

2020 Modality Reimbursement Tool – Sacroiliac Joint

2020 Reimbursement Guide

COOLIEF* Cooled RF Procedure Scenarios

6 Practical Steps that may Improve Billing Efficiency Infographic

 

Related Articles

February 4, 2020 in Acute/Surgical Pain, Patient Experience, Posts

WHEN YOU PRESCRIBE OPIOIDS, MORE THAN ONE LIFE IS AT RISK

WHEN YOU PRESCRIBE OPIOIDS, MORE THAN ONE LIFE IS AT RISK BY THE NUMBERS 600% WOMEN ARE BECOMING MORE AT RISK From 1999 to 2016, the rate of death from…
Read More
December 16, 2019 in Industry News

AMSSM Awards $300,000 Research Grant for Treatment of OA Using RFA Technology

AMSSM Awards $300,000 Research Grant for Treatment of OA Using RFA Technology The American Medical Society for Sports Medicine (AMSSM) and its Collaborative Research Network (CRN) are pleased to announce…
Read More
November 18, 2019 in Acute/Surgical Pain, ON-Q, Opioids, Patient Experience, Posts

Every Day Counts

With opioid addiction, EVERY DAY COUNTS. Protect your patients from DAY 1 with long-lasting, opioid-sparing ON-Q*. Mercy Medical Center Mt. Shasta Establishing Surgical Excellence through Opioid Reduction   65% Reduction…
Read More
September 17, 2019 in Industry News

BIOQ PHARMA ANNOUNCES PARTNERSHIP WITH AVANOS MEDICAL

Read More
September 17, 2019 in Acute/Surgical Pain, Posts

BioQ Pharma Announces Partnership with Avanos Medical

SAN FRANCISCO, Sept. 17, 2019: BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced that it has entered into a Development, Supply, Distribution Agreement with Avanos Medical, Inc. (NYSE: AVNS,…
Read More
May 8, 2019 in Industry News

Managing post-surgical pain without opioids

Read More

FOOTNOTES:

  1. U.S. Government Accountability Office (GAO): “Private Health Insurance: http://www.gao.gov/products/GAO-11-268
  1. MGMA Connection, “How to avoid ‘unclean’ claims,” by Amber Taufen, MA, March 28, 2014. http://www.mgma.com/practice-resources/mgma-connection-plus/online-only/2014/march/how-to-avoid-unclean-claims
  1. Becker’s Hospital CFO Report, “4 ways healthcare organizations can reduce claim denials,” by Kelly Gooch, July 26, 2016.http://www.beckershospitalreview.com/finance/4-ways-healthcare-organizations-can-reduce-claim-denials.html

Disclaimer:

This information is derived from a variety of public sources and is provided for informational purposes only. Payment varies by geographic location, coverage and payer. It does not constitute reimbursement or legal advice. It is not intended to increase or maximize reimbursement by any payer. Avanos does not warrant or guarantee that the use of this information will result in coverage or payment. Avanos encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered.

Avanos recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage, and reimbursement matters. Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding, or site of service requirements.